journal article·2013-04-23

Efficient Pro-survival/angiogenic miRNA Delivery by an MRI-Detectable Nanomaterial

Renata S. M. Gomes, Ricardo Pires das Neves, Lowri Cochlin, Ana Lima, Rui Carvalho, Petra Korpisalo, Galina Dragneva, Mikko Turunen, Timmo Liimatainen, Kieran Clarke, Seppo Ylä-Herttuala, Carolyn Carr, Lino Ferreira

ACS Nano· Volume 7· Issue 4
Publisher page

Abstract

Herein, we report the use of biodegradable nanoparticles (NPs) containing perfluoro-1,5-crown ether (PFCE), a fluorine-based compound (NP170-PFCE) with the capacity to track cells in vivo by magnetic ressonance imaging (MRI) and efficiently release miRNA. NP170-PFCE complexed with miRNAs accumulate whitin the cell's endolysosomal compartment and interact with higher frequency with argonaute2 (Ago2) and GW182 proteins, which are involved in the biological action of miRNAs, than commercial complexes formed by commercial reagents and miRNA, which in turn accumulate in the cell cytoplasm. The release of miRNA132 (miR132) from the NPs increased 3-fold the survival of endothelial cells (ECs) transplanted in vivo and 3.5-fold the blood perfusion in ischemic limbs relatively to control.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: MicroRNA in disease regulation · RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

CNC, Center for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal

Biocant, Center of Innovation in Biotechnology, 3060-197 Cantanhede, Portugal

Cardiovascular Biology & Medicine, Rayne Institute, University College, London, U.K.

Cardiac Metabolism Research Group, Department of Physiology, Anatomy & Genetics, University of Oxford, U.K.

A.I. Virtanen Institute, Department of Biotechnology and Molecular Medicine, University of Eastern Finland, Finland

References (30)

Show source-provided references
1. Haider H. · J. Mol. Cell Cardiol. · 2008 · 45 · 55410.1016/j.yjmcc.2008.05.004 ↗
2. Ferreira L. · Cardiovasc. Hematol. Disord. Drug Targets · 2010 · 10 · 17310.2174/1871529X11006030173 ↗
3. Hu S. · Circulation · 2011 · 124 · S27
4. Bonauer A. · Science · 2009 · 324 · 171010.1126/science.1174381 ↗
5. Fasanaro P. · Pharmacol. Ther. · 2010 · 125 · 9210.1016/j.pharmthera.2009.10.003 ↗
6. Bartel D. P. · Cell · 2004 · 116 · 28110.1016/S0092-8674(04)00045-5 ↗
7. Shi M. A. · Sci. Signal. · 2010 · 3 · pe40
8. Kota J. · Cell · 2009 · 137 · 100510.1016/j.cell.2009.04.021 ↗
9. Anand S. · Nat. Med. · 2010 · 16 · 90910.1038/nm.2186 ↗
10. Chen Y. · Mol. Ther. · 2010 · 18 · 165010.1038/mt.2010.136 ↗
11. Srinivas M. · Biomaterials · 2010 · 31 · 707010.1016/j.biomaterials.2010.05.069 ↗
12. Shi S. J. · Pharm. Res. · 2012 · 29 · 9710.1007/s11095-011-0514-6 ↗
13. Cheng C. J. · Mol. Pharm. · 2012 · 9 · 148110.1021/mp300081s ↗
14. Gibbings D. · Trends Cell Biol. · 2010 · 20 · 49110.1016/j.tcb.2010.06.001 ↗
15. Gibbings D. J. · Nat. Cell Biol. · 2009 · 11 · 114310.1038/ncb1929 ↗
16. Paulo C. S. · Nanotechnology · 2011 · 22 · 49400210.1088/0957-4484/22/49/494002 ↗
17. Ahrens E. T. · Nat. Biotechnol. · 2005 · 23 · 98310.1038/nbt1121 ↗
18. Partlow K. C. · FASEB J. · 2007 · 21 · 164710.1096/fj.06-6505com ↗
19. Mignion L. · Magn. Reson. Med. · 2013 · 69 · 24810.1002/mrm.24245 ↗
20. Luo D. · Nat. Biotechnol. · 2000 · 18 · 3310.1038/71889 ↗
21. Ferreira L. · Cell Stem Cell · 2008 · 3 · 13610.1016/j.stem.2008.07.020 ↗
22. Arbab A. S. · Blood · 2004 · 104 · 121710.1182/blood-2004-02-0655 ↗
23. Ghosh G. · J. Clin. Invest. · 2010 · 120 · 414110.1172/JCI42980 ↗
24. Huang J. G. · Nanotoday · 2011 · 610.1016/j.nantod.2011.08.002 ↗
25. Iwasaki S. · Mol. Cell · 2010 · 39 · 29210.1016/j.molcel.2010.05.015 ↗
26. Arispe N. · J. Biol. Chem. · 2000 · 275 · 3083910.1074/jbc.M005226200 ↗
27. Katare R. · Circ. Res. · 2011 · 109 · 89410.1161/CIRCRESAHA.111.251546 ↗
28. Yang F. · Proc. Natl. Acad. Sci. U.S.A. · 2010 · 107 · 331710.1073/pnas.0905432106 ↗
29. Silva E. A. · Proc. Natl. Acad. Sci. U.S.A. · 2008 · 105 · 1434710.1073/pnas.0803873105 ↗
30. Horisawa E. · Pharm. Res. · 2002 · 19 · 13210.1023/A:1014260513728 ↗